Teva Pharmaceutical Industries EBITDA Margin 2012-2025 | TEVA
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Teva Pharmaceutical Industries (TEVA) over the last 10 years. The current EBITDA margin for Teva Pharmaceutical Industries as of December 31, 2025 is
Unlock Macrotrends Premium
Start 7-Day Free Trial
Teva Pharmaceutical Industries EBITDA Margin Historical Data
Date
TTM Revenue
TTM EBITDA
EBITDA Margin
2025-12-31
$17.26B
$3.16B
18.31%
2025-09-30
$16.78B
$2.24B
13.34%
2025-06-30
$16.63B
$1.92B
11.53%
2025-03-31
$16.62B
$1.47B
8.82%
2024-12-31
$16.54B
$0.76B
4.57%
2024-09-30
$16.77B
$2.14B
12.75%
2024-06-30
$16.29B
$1.96B
12.01%
2024-03-31
$16.00B
$1.35B
8.44%
2023-12-31
$15.85B
$1.59B
10.01%
2023-09-30
$15.27B
$-0.08B
-0.53%
2023-06-30
$15.02B
$0.03B
0.21%
2023-03-31
$14.93B
$-0.21B
-1.39%
2022-12-31
$14.93B
$-0.89B
-5.96%
2022-09-30
$15.14B
$0.13B
0.87%
2022-06-30
$15.43B
$0.37B
2.37%
2022-03-31
$15.56B
$1.84B
11.85%
2021-12-31
$15.88B
$3.05B
19.18%
2021-09-30
$16.23B
$-1.16B
-7.13%
2021-06-30
$16.32B
$-1.46B
-8.96%
2021-03-31
$16.28B
$-1.80B
-11.03%
2020-12-31
$16.66B
$-2.01B
-12.09%
2020-09-30
$16.67B
$2.38B
14.26%
2020-06-30
$16.79B
$2.04B
12.16%
2020-03-31
$17.10B
$1.29B
7.56%
2019-12-31
$16.89B
$1.28B
7.57%
2019-09-30
$16.40B
$0.84B
5.12%
2019-06-30
$16.83B
$1.00B
5.93%
2019-03-31
$17.36B
$1.78B
10.24%
2018-12-31
$18.27B
$3.23B
17.69%
2018-09-30
$19.69B
$-9.38B
-47.64%
2018-06-30
$20.78B
$-8.97B
-43.15%
2018-03-31
$21.80B
$-14.72B
-67.50%
2017-12-31
$22.39B
$-15.37B
-68.67%
2017-09-30
$23.48B
$-3.11B
-13.24%
2017-06-30
$23.43B
$-3.08B
-13.16%
2017-03-31
$22.74B
$3.46B
15.23%
2016-12-31
$21.90B
$3.68B
16.79%
2016-09-30
$20.29B
$4.20B
20.71%
2016-06-30
$19.55B
$4.98B
25.47%
2016-03-31
$19.48B
$4.87B
24.98%
2015-12-31
$19.65B
$4.66B
23.71%
2015-09-30
$19.94B
$5.96B
29.89%
2015-06-30
$20.17B
$5.89B
29.18%
2015-03-31
$20.25B
$6.06B
29.92%
2014-12-31
$20.27B
$6.11B
30.14%
2014-09-30
$20.53B
$5.97B
29.06%
2014-06-30
$20.54B
$5.72B
27.84%
2014-03-31
$20.41B
$4.19B
20.54%
2013-12-31
$20.31B
$4.08B
20.08%
2013-09-30
$20.13B
$4.61B
22.87%
2013-06-30
$20.05B
$3.57B
17.81%
2013-03-31
$20.12B
$5.04B
25.07%
2012-12-31
$20.32B
$5.17B
25.46%
2012-09-30
$20.74B
$4.56B
21.99%
2012-06-30
$20.12B
$5.49B
27.30%
2012-03-31
$19.33B
$4.92B
25.46%
2011-12-31
$18.31B
$4.61B
25.16%
2011-09-30
$17.05B
$4.25B
24.93%
2011-06-30
$16.96B
$4.42B
26.04%
2011-03-31
$16.55B
$4.90B
29.63%
2010-12-31
$16.12B
$4.84B
30.02%
2010-09-30
$15.51B
$4.34B
27.97%
2010-06-30
$14.81B
$3.99B
26.97%
2010-03-31
$14.41B
$3.70B
25.66%
2009-12-31
$13.90B
$3.34B
24.00%
2009-09-30
$12.95B
$3.65B
28.17%
2009-06-30
$12.24B
$3.32B
27.12%
2009-03-31
$11.66B
$3.07B
26.31%
2008-12-31
$11.09B
$3.16B
28.54%
2008-09-30
$10.81B
$3.14B
29.07%
2008-06-30
$10.34B
$3.13B
30.29%
2008-03-31
$9.90B
$3.14B
31.70%
2007-12-31
$9.41B
$2.92B
30.99%
2007-09-30
$9.11B
$3.03B
33.31%
2007-06-30
$9.03B
$2.99B
33.15%
2007-03-31
$8.82B
$2.90B
32.91%
2006-12-31
$8.41B
$2.62B
31.20%
2006-09-30
$7.53B
$2.07B
27.42%
2006-06-30
$6.56B
$1.65B
25.19%
2006-03-31
$5.62B
$1.29B
22.91%
2005-12-31
$5.25B
$1.31B
24.94%
2005-09-30
$5.17B
$0.69B
13.28%
2005-06-30
$5.10B
$0.69B
13.58%
2005-03-31
$5.05B
$0.68B
13.48%
2004-12-31
$4.80B
$0.61B
12.67%
2004-09-30
$4.42B
$1.22B
27.69%
2004-06-30
$3.98B
$1.10B
27.67%
2004-03-31
$3.57B
$0.99B
27.64%
2003-12-31
$3.28B
$0.91B
27.84%
2003-09-30
$3.10B
$0.74B
23.87%
2003-06-30
$2.92B
$0.67B
22.79%
2003-03-31
$2.73B
$0.60B
21.83%
2002-12-31
$2.52B
$0.53B
20.85%
2002-09-30
$2.32B
$0.45B
19.61%
2002-06-30
$2.19B
$0.43B
19.68%
2002-03-31
$2.13B
$0.41B
19.04%
2001-12-31
$2.08B
$0.38B
18.14%
2001-09-30
$2.03B
$0.78B
38.59%
2001-06-30
$1.97B
$1.13B
57.48%
2001-03-31
$1.90B
$1.49B
78.35%
2000-12-31
$1.75B
$1.75B
100.00%
2000-09-30
$1.61B
$1.61B
100.00%
2000-06-30
$1.48B
$1.48B
100.00%
2000-03-31
$1.33B
$1.33B
100.00%
1999-12-31
$1.28B
$1.28B
100.00%
1999-09-30
$1.20B
$1.20B
100.00%
1999-06-30
$1.18B
$1.18B
100.00%
1999-03-31
$1.14B
$1.14B
100.00%
1998-12-31
$1.12B
$1.12B
100.00%
1998-09-30
$1.11B
$1.11B
100.00%
1998-06-30
$1.10B
$1.10B
100.00%
1998-03-31
$1.12B
$1.12B
100.00%
1997-12-31
$1.12B
$1.12B
100.00%
1997-09-30
$1.10B
$1.10B
100.00%
1997-06-30
$1.05B
$1.05B
100.00%
1997-03-31
$1.00B
$1.00B
100.00%
1996-12-31
$0.92B
$0.92B
100.00%
1996-09-30
$0.84B
$0.84B
100.00%
1996-06-30
$0.77B
$0.77B
100.00%
1996-03-31
$0.70B
$0.70B
100.00%
1995-12-31
$0.67B
$0.67B
100.00%
1995-09-30
$0.64B
$0.64B
100.00%
1995-06-30
$0.61B
$0.61B
100.00%
1995-03-31
$0.60B
$0.50B
83.11%
1994-12-31
$0.59B
$0.38B
63.95%
1994-09-30
$0.56B
$0.23B
41.94%
1994-06-30
$0.54B
$0.11B
20.85%
1994-03-31
$0.52B
$0.09B
17.50%
1993-12-31
$0.50B
$0.09B
17.37%
1993-09-30
$0.49B
$0.44B
90.10%
1993-06-30
$0.45B
$0.31B
67.33%
1993-03-31
$0.55B
$0.30B
55.78%
1992-12-31
$0.52B
$0.18B
34.67%
1992-06-30
$0.50B
$-0.05B
-10.71%
1991-03-31
$0.31B
$0.04B
13.36%
Sector
Industry
Market Cap
Revenue
Medical Medical - Generic Drugs $39.071B
$17.258B
Teva Pharmaceutical Industries Limited is a global pharmaceutical company that develops, manufactures, and markets both branded and generic drugs, as well as active pharmaceutical ingredients in North America, Europe, Latin America, India, and Israel. Teva's generic product portfolio includes tablets, capsules, liquids, ointments, creams, liquids, injectables, and inhalants. The company's branded products include Copaxone, Austedo, respiratory products like ProAir and Qvar and Ajovy. Teva operates through three segments, North America, Europe and International Markets, each of which includes generics, specialty and over-the-counter products. Teva acquired Allergan's generics business Actavis Generics. The company also acquired Allergan's Anda Inc. Teva acquired Auspex Pharmaceuticals and Barr. Teva has strengthened its position in Europe through its acquisition of Germany's second largest generics producer, ratiopharm.
